Extracellular miRNAs: Origin, function and biomarkers in hepatic diseases

Journal of Biomedical Nanotechnology

Volumn 10, Issue 10, 2014, Pages 2865-2890

  Zhou, Bingcong ^a   Li, Zhiyang ^a,b   Yang, Haowen ^a   He, Nongyue ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Extracellular miRNAs; Hepatic diseases; Intercellular communication; Origin

Indexed keywords

BIOMARKERS; CELL SIGNALING; DIAGNOSIS; MAMMALS; NONINVASIVE MEDICAL PROCEDURES; TRANSCRIPTION;

CELL-CELL COMMUNICATIONS; DIAGNOSTIC BIOMARKERS; EXTRACELLULAR; HEPATIC DISEASE; INTERCELLULAR COMMUNICATIONS; NON-INVASIVE DIAGNOSTICS; ORIGIN; POST-TRANSCRIPTIONAL REGULATIONS;

RNA;

BIOLOGICAL MARKER; EXTRACELLULAR MICRORNA; MICRORNA; UNCLASSIFIED DRUG;

BIOGENESIS; BODY FLUID; CELL COMMUNICATION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; NONHUMAN; PREDICTION; REVIEW; RNA STABILITY; RNA TRANSLATION; TOXIC HEPATITIS; TRANSCRIPTION REGULATION; ANIMAL; BIOSYNTHESIS; BLOOD; EXTRACELLULAR SPACE; GENETICS; METABOLISM;

ANIMALS; BIOLOGICAL MARKERS; CELL COMMUNICATION; EXTRACELLULAR SPACE; HUMANS; LIVER DISEASES; MICRORNAS;

EID: 84905644292     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1993     Document Type: Review

References (406)

1. R. C. Lee, R. L. Feinbaum, and V. Ambros, The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843 (1993).
2. D. P. Bartel, MicroRNAs: Target recognition and regulatory functions. Cell 136, 215 (2009).
3. D. P. Bartel, MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116, 281 (2004).
4. V. Ambros, MicroRNAs: Tiny regulators with great potential. Cell 107, 823 (2001).
5. R. C. Lee and V. Ambros, An extensive class of small RNAs in Caenorhabditis elegans. Science 294, 862 (2001).
6. L. Zhang, B. Xu, S. Chen, K. Lu, C. Liu, Y. Wang, Y. Zhao, X. Zhang, D. Liu, and M. Chen, The complex roles of microRNAs in the metastasis of renal cell carcinoma. J. Nanosci. Nanotechnol. 13, 3195 (2013).
7. J. Feng and J. Chen, In silico analysis the complementarity of tomato microRNA/microRNA&z.ast; sequences with Cucumber mosaic virus (CMV) genomic RNAs. J. Nanosci. Nanotechnol. 13, 4421 (2013).
8. X. Li, X. Zhang, T. Wang, C. Sun, T. Jin, H. Yan, J. Zhang, X. Li, T. Geng, C. Chen, A. Ma, and S. Li, Regulation by bisoprolol for cardiac microRNA expression in a rat volume-overload heart failure model. J. Nanosci. Nanotechnol. 13, 5267 (2013).
9. M. Pan, Q. Ge, H. Li, Q. Yang, J. Lu, D. Zhang, and Z. Lu, Sequencing the miRNAs in maternal plasma from women before and after parturition. J. Nanosci. Nanotechnol. 12, 4035 (2012).
10. J. Chen, J. Feng, Q. Liao, S. Chen, J. Zhang, Q. Lang, Z. Du, X. Zheng, and P. Ouyang, Analysis of tomato microRNAs expression profile induced by Cucumovirus and Tobamovirus infections. J. Nanosci. Nanotechnol. 12, 143 (2012).
11. M. Muniz-Miranda, C. Gellini, P. R. Salvi, V. Schettino, M. Pagliai, and M. Innocenti, Nanostructured Ag platforms as biosensors of nucleobase chains. J. Nanosci. Nanotechnol. 11, 8763 (2011).
12. K. Sun and E. C. Lai, Adult-specific functions of animal microRNAs. Nat. Rev. Genet. 14, 535 (2013).
13. C. M. Croce and G. A. Calin, MiRNAs, cancer, and stem cell division. Cell 122, 6 (2005).
14. V. Ambros, The functions of animal microRNAs. Nature 431, 350 (2004).
15. W. P. Kloosterman and R. H. Plasterk, The diverse functions of microRNAs in animal development and disease. Dev. Cell 11, 441 (2006).
16. R. Ma, T. Jiang, and X. Kang, Circulating microRNAs in cancer: Origin, function and application. J. Exp. Clin. Cancer Res. 31, 38 (2012).
17. W. Wei, J. Hou, O. Alder, X. Ye, S. Lee, R. Cullum, A. Chu, Y. Zhao, S. M. Warner, D. A. Knight, D. Yang, S. J. Jones, M. A. Marra, and P. A. Hoodless, Genome-wide microRNA and messenger RNA profiling in rodent liver development implicates mir302b and mir20a in repressing transforming growth factor-beta signaling. Hepatology 57, 2491 (2013).
18. Y. Chen and C. M. Verfaillie, MicroRNAs: The fine modulators of liver development and function. Liver Int. 1 (2014).
19. X. W. Wang, N. H. Heegaard, and H. Orum, MicroRNAs in liver disease. Gastroenterology 142, 1431 (2012).
20. G. Szabo and S. Bala, MicroRNAs in liver disease. Nat. Rev. Gastroenterol. Hepatol. 10, 542 (2013).
21. G. A. Michelotti, M. V. Machado, and A. M. Diehl, NAFLD, NASH and liver cancer. Nat. Rev. Gastroenterol. Hepatol. 10, 656 (2013).
22. H. Yang, M. E. Cho, T. W. Li, H. Peng, K. S. Ko, J. M. Mato, and S. C. Lu, MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma. J. Clin. Invest. 123, 285 (2013).
23. S. Giordano and A. Columbano, MicroRNAs: New tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology 57, 840 (2013).
24. M. H. van der Ree, J. de Bruijne, N. A. Kootstra, P. L. Jansen, and H. W. Reesink, MicroRNAs: Role and therapeutic targets in viral hepatitis. Antivir. Ther. (2014).
25. X. Xu, Z. Fan, L. Kang, J. Han, C. Jiang, X. Zheng, Z. Zhu, H. Jiao, J. Lin, K. Jiang, L. Ding, H. Zhang, L. Cheng, H. Fu, Y. Song, Y. Jiang, J. Liu, R. Wang, Du N, and Q. Ye, Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J. Clin. Invest. 123, 630 (2013).
26. M. Jiang, R. Broering, M. Trippler, J. Wu, E. Zhang, X. Zhang, G. Gerken, M. Lu, and J. F. Schlaak, MicroRNA-155 controls Tolllike receptor 3- and hepatitis C virus-induced immune responses in the liver. J. Viral Hepat. 21, 99 (2014).
27. R. Vuppalanchi, T. Liang, C. P. Goswami, R. Nalamasu, L. Li, D. Jones, R. Wei, W. Liu, V. Sarasani, S. C. Janga, and N. Chalasani, Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosis. PLoS One 8, e74471 (2013).
28. Y. J. Chen, J. M. Zhu, H. Wu, J. Fan, J. Zhou, J. Hu, Q. Yu, T. T. Liu, L. Yang, C. L. Wu, X. L. Guo, X. W. Huang, and X. Z. Shen, Circulating microRNAs as a fingerprint for liver cirrhosis. PLoS One 8, e66577 (2013).
29. C. Roderburg, M. Luedde, C. D. Vargas, M. Vucur, T. Mollnow, H. W. Zimmermann, A. Koch, C. Hellerbrand, R. Weiskirchen, N. Frey, F. Tacke, C. Trautwein, and T. Luedde, MiR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. J. Hepatol. 58, 736 (2013).
30. C. Roderburg, G. W. Urban, K. Bettermann, M. Vucur, H. Zimmermann, S. Schmidt, J. Janssen, C. Koppe, P. Knolle, M. Castoldi, F. Tacke, C. Trautwein, and T. Luedde, Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53, 209 (2011).
31. S. Endo, A. Yano, T. Fukami, M. Nakajima, and T. Yokoi, Involvement of miRNAs in the early phase of halothane-induced liver injury. Toxicology 319, 75 (2014).
32. P. Thulin, G. Nordahl, M. Gry, G. Yimer, E. Aklillu, E. Makonnen, G. Aderaye, L. Lindquist, C. M. Mattsson, B. Ekblom, D. J. Antoine, B. K. Park, S. Linder, A. H. Harrill, P. B. Watkins, B. Glinghammar, and I. Schuppe-Koistinen, Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts. Liver Int. 34, 367 (2013).
33. J. D. Arroyo, J. R. Chevillet, E. M. Kroh, I. K. Ruf, C. C. Pritchard, D. F. Gibson, P. S. Mitchell, C. F. Bennett, E. L. Pogosova-Agadjanyan, D. L. Stirewalt, J. F. Tait, and M. Tewari, Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. USA 108, 5003 (2011).
34. P. Diehl, A. Fricke, L. Sander, J. Stamm, N. Bassler, N. Htun, M. Ziemann, T. Helbing, A. El-Osta, J. B. Jowett, and K. Peter, Microparticles: Major transport vehicles for distinct microRNAs in circulation. Cardiovasc. Res. 93, 633 (2012).
35. K. Cuk, M. Zucknick, J. Heil, D. Madhavan, S. Schott, A. Turchinovich, D. Arlt, M. Rath, C. Sohn, A. Benner, H. Junkermann, A. Schneeweiss, and B. Burwinkel, Circulating microRNAs in plasma as early detection markers for breast cancer. Int. J. Cancer 132, 1602 (2013).
36. M. Tsujiura, D. Ichikawa, S. Komatsu, A. Shiozaki, H. Takeshita, T. Kosuga, H. Konishi, R. Morimura, K. Deguchi, H. Fujiwara, K. Okamoto, and E. Otsuji, Circulating microRNAs in plasma of patients with gastric cancers. Br. J. Cancer 102, 1174 (2010).
37. R. J. White, Transcription by RNA polymerase III: More complex than we thought. Nat. Rev. Genet. 12, 459 (2011).
38. X. Cai, C. H. Hagedorn, and B. R. Cullen, Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. Rna 10, 1957 (2004).
39. F. Ozsolak, L. L. Poling, Z. Wang, H. Liu, X. S. Liu, R. G. Roeder, X. Zhang, J. S. Song, and D. E. Fisher, Chromatin structure analyses identify miRNA promoters. Genes Dev. 22, 3172 (2008).
40. D. L. Corcoran, K. V. Pandit, B. Gordon, A. Bhattacharjee, N. Kaminski, and P. V. Benos, Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS One 4, e5279 (2009).
41. A. Turchinovich, L. Weiz, and B. Burwinkel, Extracellular miRNAs: The mystery of their origin and function. Trends Biochem. Sci. 37, 460 (2012).
42. H. Y. Hu, Z. Yan, Y. Xu, H. Hu, C. Menzel, Y. H. Zhou, W. Chen, and P. Khaitovich, Sequence features associated with microRNA strand selection in humans and flies. BMC Genomics 10, 413 (2009).
43. T. W. Nilsen, Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet. 23, 243 (2007).
44. P. H. Olsen and V. Ambros, The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev. Biol. 216, 671 (1999).
45. D. J. Gibbings, C. Ciaudo, M. Erhardt, and O. Voinnet, Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat. Cell Biol. 11, 1143 (2009).
46. S. S. Chim, T. K. Shing, E. C. Hung, T. Y. Leung, T. K. Lau, R. W. Chiu, and Y. M. Lo, Detection and characterization of placental microRNAs in maternal plasma. Clin. Chem. 54, 482 (2008).
47. P. S. Mitchell, R. K. Parkin, E. M. Kroh, B. R. Fritz, S. K. Wyman, E. L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K. C. O'Briant, A. Allen, D. W. Lin, N. Urban, C. W. Drescher, B. S. Knudsen, D. L. Stirewalt, R. Gentleman, R. L. Vessella, P. S. Nelson, D. B. Martin, and M. Tewari, Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 105, 10513 (2008).
48. J. N. Boeckel, C. E. Thomé, D. Leistner, A. M. Zeiher, S. Fichtlscherer, and S. Dimmeler, Heparin selectively affects the quantification of microRNAs in human blood samples. Clin. Chem. 59, 1125 (2013).
49. E. K. Ng, W. W. Chong, H. Jin, E. K. Lam, V. Y. Shin, J. Yu, T. C. Poon, S. S. Ng, and J. J. Sung. Differential expression of microRNAs in plasma of patients with colorectal cancer: A potential marker for colorectal cancer screening. Gut 58, 1375 (2009).
50. Z. Huang, D. Huang, S. Ni, Z. Peng, W. Sheng, and X. Du, Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer 127, 118 (2010).
51. M. Boeri, C. Verri, D. Conte, L. Roz, P. Modena, F. Facchinetti, E. Calabro, C. M. Croce, U. Pastorino, and G. Sozzi, MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc. Natl. Acad. Sci. U S A 108, 3713 (2011).
52. X. Chen, Y. Ba, L. Ma, X. Cai, Y. Yin, K. Wang, J. Guo, Y. Zhang, J. Chen, X. Guo, Q. Li, X. Li, W. Wang, Y. Zhang, J. Wang, X. Jiang, Y. Xiang, C. Xu, P. Zheng, J. Zhang, R. Li, H. Zhang, X. Shang, T. Gong, G. Ning, J. Wang, K. Zen, J. Zhang, and C. Y. Zhang, Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997 (2008).
53. R. Liu, X. Chen, Y. Du, W. Yao, L. Shen, C. Wang, Z. Hu, R. Zhuang, G. Ning, C. Zhang, Y. Yuan, Z. Li, K. Zen, Y. Ba, and C. Y. Zhang, Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin. Chem. 58, 610 (2012).
54. N. Liu, R. X. Cui, Y. Sun, R. Guo, Y. P. Mao, L. L. Tang, W. Jiang, X. Liu, Y. K. Cheng, Q. M. He, W. C. Cho, L. Z. Liu, L. Li, and J. Ma, A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma. Int. J. Cancer 134, 1359 (2014).
55. N. J. Park, H. Zhou, D. Elashoff, B. S. Henson, D. A. Kastratovic, E. Abemayor, and D. T. Wong, Salivary microRNA: Discovery, characterization, and clinical utility for oral cancer detection. Clin. Cancer Res. 15, 5473 (2009).
56. J. H. Matse, J. Yoshizawa, X. Wang, D. Elashoff, J. G. Bolscher, E. C. Veerman, E. Bloemena, and D. T. Wong, Discovery and prevalidation of salivary extracellular microRNA biomarkers panel for the noninvasive detection of benign and malignant parotid gland tumors. Clin. Cancer Res. 19, 3032 (2013).
57. J. M. Lorenzen, I. Volkmann, J. Fiedler, M. Schmidt, I. Scheffner, H. Haller, W. Gwinner, and T. Thum, Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients. Am. J. Transplant. 11, 2221 (2011).
58. L. Cheng, X. Sun, B. J. Scicluna, B. M. Coleman, and A. F. Hill, Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine. Kidney Int. 1 (2013).
59. C. Wang, C. Yang, X. Chen, B. Yao, C. Yang, C. Zhu, L. Li, J. Wang, X. Li, Y. Shao, Y. Liu, J. Ji, J. Zhang, K. Zen, C. Y. Zhang, and C. Zhang, Altered profile of seminal plasma microRNAs in the molecular diagnosis of male infertility. Clin. Chem. 57, 1722 (2011).
60. W. Wu, Z. Hu, Y. Qin, J. Dong, J. Dai, C. Lu, W. Zhang, H. Shen, Y. Xia, and X. Wang, Seminal plasma microRNAs: Potential biomarkers for spermatogenesis status. Mol. Hum. Reprod. 18, 489 (2012).
61. C. Belleannee, C. Legare, E. Calvo, V. Thimon, and R. Sullivan, MicroRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy. Hum. Reprod. 28, 1455 (2013).
62. Q. Zhou, M. Li, X. Wang, Q. Li, T. Wang, Q. Zhu, X. Zhou, X. Wang, X. Gao, and X. Li, Immune-related microRNAs are abundant in breast milk exosomes. Int. J. Biol. Sci. 8, 118 (2012).
63. E. M. Munch, R. A. Harris, M. Mohammad, A. L. Benham, S. M. Pejerrey, L. Showalter, M. Hu, C. D. Shope, P. D. Maningat, P. H. Gunaratne, M. Haymond, and K. Aagaard, Transcriptome profiling of microRNA by Next-Gen deep sequencing reveals known and novel miRNA species in the lipid fraction of human breast milk. PLoS One 8, e50564 (2013).
64. J. A. Weber, D. H. Baxter, S. Zhang, D. Y. Huang, K. H. Huang, M. J. Lee, D. J. Galas, and K. Wang, The microRNA spectrum in 12 body fluids. Clin. Chem. 56, 1733 (2010).
65. H. Valadi, K. Ekstrom, A. Bossios, M. Sjostrand, J. J. Lee, and J. O. Lotvall, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654 (2007).
66. D. D. Taylor and C. Gercel-Taylor, The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids. Front. Genet. 4, 142 (2013).
67. A. Zernecke, K. Bidzhekov, H. Noels, E. Shagdarsuren, L. Gan, B. Denecke, M. Hristov, T. Koppel, M. N. Jahantigh, E. Lutgens, S. Wang, E. N. Olson, A. Schober, and C. Weber, Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal. 2, a81 (2009).
68. K. J. Rayner and E. J. Hennessy, Extracellular communication via microRNA: Lipid particles have a new message. J. Lipid Res. 54, 1174 (2013).
69. E. Cocucci, G. Racchetti, and J. Meldolesi, Shedding microvesicles: Artefacts no more. Trends Cell Biol. 19, 43 (2009).
70. D. M. Pegtel, K. Cosmopoulos, D. A. Thorley-Lawson, M. A. van Eijndhoven, E. S. Hopmans, J. L. Lindenberg, T. D. de Gruijl, T. Wurdinger, and J. M. Middeldorp, Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. USA 107, 6328 (2010).
71. M. Mittelbrunn, C. Gutierrez-Vazquez, C. Villarroya-Beltri, S. Gonzalez, F. Sanchez-Cabo, M. A. Gonzalez, A. Bernad, and F. Sanchez-Madrid, Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2, 282 (2011).
72. N. Kosaka, F. Takeshita, Y. Yoshioka, K. Hagiwara, T. Katsuda, M. Ono, and T. Ochiya, Exosomal tumor-suppressive microRNAs as novel cancer therapy: "Exocure" is another choice for cancer treatment. Adv. Drug Deliv. Rev. 65, 376 (2013).
73. J. Zhou, Y. S. Li, P. Nguyen, K. C. Wang, A. Weiss, Y. C. Kuo, J. J. Chiu, J. Y. Shyy, and S. Chien, Regulation of vascular smooth muscle cell turnover by endothelial cell-secreted microRNA-126: Role of shear stress. Circ. Res. 113, 40 (2013).
74. C. Villarroya-Beltri, C. Gutierrez-Vazquez, F. Sanchez-Cabo, D. Perez-Hernandez, J. Vazquez, N. Martin-Cofreces, D. J. Martinez-Herrera, A. Pascual-Montano, M. Mittelbrunn, and F. Sanchez-Madrid, Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat. Commun. 4, 2980 (2013).
75. T. Umezu, K. Ohyashiki, M. Kuroda, and J. H. Ohyashiki, Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene 32, 2747 (2013).
76. S. Ohno, M. Takanashi, K. Sudo, S. Ueda, A. Ishikawa, N. Matsuyama, K. Fujita, T. Mizutani, T. Ohgi, T. Ochiya, N. Gotoh, and M. Kuroda, Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol. Ther. 21, 185 (2013).
77. G. Raposo and W. Stoorvogel, Extracellular vesicles: Exosomes, microvesicles, and friends. J. Cell Biol. 200, 373 (2013).
78. K. Wang, S. Zhang, J. Weber, D. Baxter, and D. J. Galas, Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 38, 7248 (2010).
79. A. Turchinovich, L. Weiz, A. Langheinz, and B. Burwinkel, Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39, 7223 (2011).
80. L. Li, D. Zhu, L. Huang, J. Zhang, Z. Bian, X. Chen, Y. Liu, C. Y. Zhang, and K. Zen, Argonaute 2 complexes selectively protect the circulating microRNAs in cell-secreted microvesicles. PLoS One 7, e46957 (2012).
81. K. C. Vickers, B. T. Palmisano, B. M. Shoucri, R. D. Shamburek, and A. T. Remaley, MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423 (2011).
82. F. Tabet, K. C. Vickers, L. F. C. Torres, C. B. Wiese, B. M. Shoucri, G. Lambert, C. Catherinet, L. Prado-Lourenco, M. G. Levin, S. Thacker, P. Sethupathy, P. J. Barter, A. T. Remaley, and K. A. Rye, HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells. Nat. Commun. 5, 3292 (2014).
83. N. Kosaka, H. Iguchi, Y. Yoshioka, F. Takeshita, Y. Matsuki, and T. Ochiya, Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 285, 17442 (2010).
84. L. Pigati, S. C. Yaddanapudi, R. Iyengar, D. J. Kim, S. A. Hearn, D. Danforth, M. L. Hastings, and D. M. Duelli, Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One 5, e13515 (2010).
85. J. Chang, E. Nicolas, D. Marks, C. Sander, A. Lerro, M. A. Buendia, C. Xu, W. S. Mason, T. Moloshok, R. Bort, K. S. Zaret, and J. M. Taylor, MiR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 1, 106 (2004).
86. X. Chen, H. Liang, J. Zhang, K. Zen, and C. Y. Zhang, Secreted microRNAs: A new form of intercellular communication. Trends Cell Biol. 22, 125 (2012).
87. Y. Zhang, D. Liu, X. Chen, J. Li, L. Li, Z. Bian, F. Sun, J. Lu, Y. Yin, X. Cai, Q. Sun, K. Wang, Y. Ba, Q. Wang, D. Wang, J. Yang, P. Liu, T. Xu, Q. Yan, J. Zhang, K. Zen, and C. Y. Zhang, Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 39, 133 (2010).
88. G. Zhuang, X. Wu, Z. Jiang, I. Kasman, J. Yao, Y. Guan, J. Oeh, Z. Modrusan, C. Bais, D. Sampath, and N. Ferrara, Tumoursecreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. Embo J. 31, 3513 (2012).
89. H. Oka, A. Tamori, T. Kuroki, K. Kobayashi, and S. Yamamoto, Prospective study of α-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 19, 61 (1994).
90. J. Collier and M. Sherman, Screening for hepatocellular carcinoma. Hepatology 27, 273 (1998).
91. J. A. Marrero and A. S. Lok, Newer markers for hepatocellular carcinoma. Gastroenterology 127, S113 (2004).
92. N. T. Zinkin, F. Grall, K. Bhaskar, H. H. Otu, D. Spentzos, B. Kalmowitz, M. Wells, M. Guerrero, J. M. Asara, T. A. Libermann, and N. H. Afdhal, Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin. Cancer Res. 14, 470 (2008).
93. J. A. Marrero, Z. Feng, Y. Wang, M. H. Nguyen, A. S. Befeler, L. R. Roberts, K. R. Reddy, D. Harnois, J. M. Llovet, D. Normolle, J. Dalhgren, D. Chia, A. S. Lok, P. D. Wagner, S. Srivastava, and M. Schwartz, α-fetoprotein, des-γ carboxyprothrombin, and lectin-bound- fetoprotein in early hepatocellular carcinoma. Gastroenterology 137, 110 (2009).
94. S. Jelic and G. C. Sotiropoulos, Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 21 Suppl 5, v59 (2010).
95. C. Verslype, O. Rosmorduc, and P. Rougier, Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 23 Suppl 7, i41 (2012).
96. A. Singhal, M. Jayaraman, D. N. Dhanasekaran, and V. Kohli, Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence. Crit. Rev. Oncol. Hematol. 82, 116 (2012).
97. X. Wang, A. Zhang, and H. Sun, Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma. Hepatology 57, 2072 (2013).
98. M. He, Z. Huang, X. Yan, X. Liao, G. Yin, A. Duan, and J. Gu, Label-free detection of hepatocellular carcinoma markers based on photoluminescence of antibody-conjugated ZnO arrays. J. Biomed. Nanotechnol. 9, 2024 (2013).
99. G. L. Wong, H. L. Chan, Y. K. Tse, H. Y. Chan, C. H. Tse, A. O. Lo, and V. W. Wong, On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir. Hepatology 59, 986 (2014).
100. M. Teng, S. Pirrie, D. G. Ward, L. K. Assi, R. G. Hughes, D. Stocken, and P. J. Johnson, Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma. Br. J. Cancer 110, 2277 (2014).
101. C. G. Moertel, T. R. Fleming, J. S. Macdonald, D. G. Haller, J. A. Laurie, and C. Tangen, An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 270, 943 (1993).
102. M. J. Duffy, Carcinoembryonic antigen as a marker for colorectal cancer: Is it clinically useful? Clin. Chem. 47, 624 (2001).
103. D. W. Park, Y. H. Kim, B. S. Kim, H. M. So, K. Won, J. O. Lee, K. J. Kong, and H. Chang, Detection of tumor markers using single-walled carbon nanotube field effect transistors. J. Nanosci. Nanotechnol. 6, 3499 (2006).
104. L. Ricci-Vitiani, D. G. Lombardi, E. Pilozzi, M. Biffoni, M. Todaro, C. Peschle, and R. De Maria, Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111 (2007).
105. R. Takagawa, S. Fujii, M. Ohta, Y. Nagano, C. Kunisaki, S. Yamagishi, S. Osada, Y. Ichikawa, and H. Shimada, Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Ann. Surg. Oncol. 15, 3433 (2008).
106. M. R. Parkhurst, J. C. Yang, R. C. Langan, M. E. Dudley, D. A. Nathan, S. A. Feldman, J. L. Davis, R. A. Morgan, M. J. Merino, R. M. Sherry, M. S. Hughes, U. S. Kammula, G. Q. Phan, R. M. Lim, S. A. Wank, N. P. Restifo, P. F. Robbins, C. M. Laurencot, and S. A. Rosenberg, T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. Mol. Ther. 19, 620 (2011).
107. M. B. Zaman, T. N. Baral, Z. J. Jakubek, J. Zhang, X. Wu, E. Lai, D. Whitfield, and K. Yu, Single-domain antibody bioconjugated near-IR quantum dots for targeted cellular imaging of pancreatic cancer. J. Nanosci. Nanotechnol. 11, 3757 (2011).
108. C. J. Verberne, T. Wiggers, K. M. Vermeulen, and K. P. de Jong, Detection of recurrences during follow-up after liver surgery for colorectal metastases: Both carcinoembryonic antigen (CEA) and imaging are important. Ann. Surg. Oncol. 20, 457 (2013).
109. R. Amri, L. G. Bordeianou, P. Sylla, and D. L. Berger, Preoperative carcinoembryonic antigen as an outcome predictor in colon cancer. J. Surg. Oncol. 108, 14 (2013).
110. Y. Peng, L. Wang, and J. Gu, Elevated preoperative carcinoembryonic antigen (CEA) and Ki67 is predictor of decreased survival in IIA stage colon cancer. World J. Surg. 37, 208 (2013).
111. D. Blat, E. Zigmond, Z. Alteber, T. Waks, and Z. Eshhar, Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells. Mol. Ther. 22, 1018 (2014).
112. M. C. Benson, I. S. Whang, A. Pantuck, K. Ring, S. A. Kaplan, C. A. Olsson, and W. H. Cooner, Prostate specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer. J. Urol. 147, 815 (1992).
113. A. W. Partin, M. W. Kattan, E. N. Subong, P. C. Walsh, K. J. Wojno, J. E. Oesterling, P. T. Scardino, and J. D. Pearson, Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multiinstitutional update. JAMA 277, 1445 (1997).
114. P. C. Walsh, Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: A multi-institutional update. J. Urol. 158, 1618 (1997).
115. G. Wu, R. H. Datar, K. M. Hansen, T. Thundat, R. J. Cote, and A. Majumdar, Bioassay of prostate-specific antigen (PSA) using microcantilevers. Nat. Biotechnol. 19, 856 (2001).
116. I. M. Thompson, D. P. Ankerst, C. Chi, M. S. Lucia, P. J. Goodman, J. J. Crowley, H. L. Parnes, and C. A. Coltman, Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower. JAMA 294, 66 (2005).
117. G. L. Liu, Y. T. Rosa-Bauza, C. M. Salisbury, C. Craik, J. A. Ellman, F. F. Chen, and L. P. Lee, Peptide-nanoparticle hybrid SERS probes for optical detection of protease activity. J. Nanosci. Nanotechnol. 7, 2323 (2007).
118. C. Cao and S. J. Sim, Preparation of highly stable oligo (ethylene glycol) derivatives-functionalized gold nanoparticles and their application in LSPR-based detection of PSA/ACT complex. J. Nanosci. Nanotechnol. 7, 3754 (2007).
119. H. Lilja, D. Ulmert, and A. J. Vickers, Prostate-specific antigen and prostate cancer: Prediction, detection and monitoring. Nat. Rev. Cancer 8, 268 (2008).
120. G. C. Jensen, X. Yu, J. D. Gong, B. Munge, A. Bhirde, S. N. Kim, F. Papadimitrakopoulos, and J. F. Rusling, Characterization of multienzyme- antibody-carbon nanotube bioconjugates for immunosensors. J. Nanosci. Nanotechnol. 9, 249 (2009).
121. W. S. Hwang and S. J. Sim, A strategy for the ultrasensitive detection of cancer biomarkers based on the LSPR response of a single AuNP. J. Nanosci. Nanotechnol. 11, 5651 (2011).
122. N. S. Elbialy, B. M. Abdol-Azim, M. W. Shafaa, L. H. El Shazly, A. H. El Shazly, and W. A. Khalil, Enhancement of the ocular therapeutic effect of prednisolone acetate by liposomal entrapment. J. Biomed. Nanotechnol. 9, 2105 (2013).
123. L. P. Bokhorst, C. H. Bangma, G. J. van Leenders, J. J. Lous, S. M. Moss, F. H. Schroder, and M. J. Roobol, Prostate-specific antigen-based prostate cancer screening: Reduction of prostate cancer mortality after correction for nonattendance and contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer. Eur. Urol. 65, 329 (2014).
124. T. J. Wilt, P. T. Scardino, S. V. Carlsson, and E. Basch, Prostatespecific antigen screening in prostate cancer: Perspectives on the evidence. J. Natl. Cancer Inst. 106, u10 (2014).
125. M. J. Stampfer, J. L. Jahn, and P. H. Gann, Further evidence that prostate-specific antigen screening reduces prostate cancer mortality. J. Natl. Cancer Inst. 106, u26 (2014).
126. F. X. Bosch, J. Ribes, M. Diaz, and R. Cleries, Primary liver cancer: Worldwide incidence and trends. Gastroenterology 127, S5 (2004).
127. D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74 (2005).
128. 3 nanoparticles combined with magnetic fluid hyperthermia on cultured liver cancer cells and xenograft liver cancers. J. Nanosci. Nanotechnol. 5, 1185 (2005).
129. J. Dou, P. Liu, and X. Zhang, Cellular response to gene expression profiles of different hepatitis C virus core proteins in the Huh-7 cell line with microarray analysis. J. Nanosci. Nanotechnol. 5, 1230 (2005).
130. P. A. Farazi and R. A. DePinho, Hepatocellular carcinoma pathogenesis: From genes to environment. Nat. Rev. Cancer 6, 674 (2006).
131. L. B. Seeff and J. H. Hoofnagle, Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Oncogene 25, 3771 (2006).
132. H. B. El-Serag and K. L. Rudolph, Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557 (2007).
133. Y. Zhang, W. Chen, J. Zhang, J. Liu, G. Chen, and C. Pope, In vitro and in vivo toxicity of CdTe nanoparticles. J. Nanosci. Nanotechnol. 7, 497 (2007).
134. A. Rakovich, T. Rakovich, V. Kelly, V. Lesnyak, A. Eychmuller, Y. P. Rakovich, and J. F. Donegan, Photosensitizer methylene bluesemiconductor nanocrystals hybrid system for photodynamic therapy. J. Nanosci. Nanotechnol. 10, 2656 (2010).
135. L. Guo, J. Huang, and L. M. Zheng, Efficient conjugation doxorubicin to bacterial magnetic nanoparticles via a triplex hands coupling reagent. J. Nanosci. Nanotechnol. 10, 6514 (2010).
136. L. Zhao, B. Yang, X. Dai, X. Wang, F. Gao, X. Zhang, and J. Tang, Glutaraldehyde mediated conjugation of amino-coated magnetic nanoparticles with albumin protein for nanothermotherapy. J. Nanosci. Nanotechnol. 10, 7117 (2010).
137. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, Global cancer statistics. CA Cancer J. Clin. 61, 69 (2011).
138. H. B. El-Serag, Hepatocellular carcinoma. N. Engl. J. Med. 365, 1118 (2011).
139. K. W. Huang, S. Y. Yang, C. Y. Yu, J. J. Chieh, C. C. Yang, H. E. Horng, C. Y. Hong, H. C. Yang, and C. C. Wu, Exploration of the relationship between the tumor burden and the concentration of vascular endothelial growth factor in liver-cancer-bearing animals using immunomagnetic reduction assay. J. Biomed. Nanotechnol. 7, 535 (2011).
140. C. Wu, L. Shi, Q. Li, J. Zhao, M. Selke, H. Yan, and X. Wang, Bioactivity of the conjugation of green-emitting CdTe quantum dots with a carborane complex. J. Nanosci. Nanotechnol. 11, 3091 (2011).
141. J. Aswathy, S. Jahnavi, R. Krishna, K. Manzoor, S. Nair, and D. Menon, Targeted labeling of cancer cells using biotin tagged avidin functionalized biocompatible fluorescent nanocrystals. J. Nanosci. Nanotechnol. 11, 7611 (2011).
142. A. Forner, J. M. Llovet, and J. Bruix, Hepatocellular carcinoma. Lancet 379, 1245 (2012).
143. Q. Li, D. Guo, R. Zhang, and X. Wang, Increasing anticancer drug internalization induced by new Au-MWCNTs nanocomposite. J. Nanosci. Nanotechnol. 12, 2192 (2012).
144. A. R. Kim, F. R. Ahmed, G. Y. Jung, S. W. Cho, D. I. Kim, and S. H. Um, Hepatocyte cytotoxicity evaluation with Zinc Oxide nanoparticles. J. Biomed. Nanotechnol. 9, 926 (2013).
145. Q. Zhang, Q. Liu, J. Shen, H. Chen, and B. Liu, Tumor delivery efficiency and apoptosis enhancement by EVO nanoparticles on murie hepatic carcinoma cell line H22. J. Biomed. Nanotechnol. 9, 1354 (2013).
146. J. Bruix, G. J. Gores, and V. Mazzaferro, Hepatocellular carcinoma: Clinical frontiers and perspectives. Gut 63, 844 (2014).
147. D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94, 153 (2001).
148. F. X. Bosch, J. Ribes, R. Cleries, and M. Diaz, Epidemiology of hepatocellular carcinoma. Clin. Liver Dis. 9, 191 (2005).
149. S. Rebouissou, P. Bioulac-Sage, and J. Zucman-Rossi, Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J. Hepatol. 48, 163 (2008).
150. Y. Zhang, Y. Jia, R. Zheng, Y. Guo, Y. Wang, H. Guo, M. Fei, and S. Sun, Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin. Chem. 56, 1830 (2010).
151. T. M. Welzel, B. I. Graubard, S. Zeuzem, H. B. El-Serag, J. A. Davila, and K. A. McGlynn, Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEERmedicare database. Hepatology 54, 463 (2011).
152. S. Huang and X. He, The role of microRNAs in liver cancer progression. Br. J. Cancer 104, 235 (2011).
153. F. Borel, P. Konstantinova, and P. L. Jansen, Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. J. Hepatol. 56, 1371 (2012).
154. A. Jemal, T. Murray, E. Ward, A. Samuels, R. C. Tiwari, A. Ghafoor, E. J. Feuer, and M. J. Thun, Cancer statistics, 2005. CA Cancer J. Clin. 55, 10 (2005).
155. Y. Fang, Q. L. Shang, J. Y. Liu, D. Li, W. Z. Xu, X. Teng, H. W. Zhao, L. J. Fu, F. M. Zhang, and H. X. Gu, Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. J. Infect. 58, 383 (2009).
156. H. Zhou, H. Wang, D. Zhou, H. Wang, Q. Wang, S. Zou, Q. Tu, M. Wu, and H. Hu, Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis. Eur. J. Cancer 46, 1056 (2010).
157. Y. Tomimaru, H. Eguchi, H. Nagano, H. Wada, S. Kobayashi, S. Marubashi, M. Tanemura, A. Tomokuni, I. Takemasa, K. Umeshita, T. Kanto, Y. Doki, and M. Mori, Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J. Hepatol. 56, 167 (2012).
158. A. P. Venook, C. Papandreou, J. Furuse, and L. L. de Guevara, The incidence and epidemiology of hepatocellular carcinoma: A global and regional perspective. Oncologist 15 Suppl 4, 5 (2010).
159. Y. Yamamoto, N. Kosaka, M. Tanaka, F. Koizumi, Y. Kanai, T. Mizutani, Y. Murakami, M. Kuroda, A. Miyajima, T. Kato, and T. Ochiya, MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers 14, 529 (2009).
160. J. Li, Y. Wang, W. Yu, J. Chen, and J. Luo, Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. Biochem. Biophys. Res. Commun. 406, 70 (2011).
161. K. Z. Qu, K. Zhang, H. Li, N. H. Afdhal, and M. Albitar, Circulating microRNAs as biomarkers for hepatocellular carcinoma. J. Clin. Gastroenterol. 45, 355 (2011).
162. V. Koberle, B. Kronenberger, T. Pleli, J. Trojan, E. Imelmann, J. Peveling-Oberhag, M. W. Welker, M. Elhendawy, S. Zeuzem, A. Piiper, and O. Waidmann, Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma. Eur. J. Cancer 49, 3442 (2013).
163. L. M. Li, Z. B. Hu, Z. X. Zhou, X. Chen, F. Y. Liu, J. F. Zhang, H. B. Shen, C. Y. Zhang, and K. Zen, Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res. 70, 9798 (2010).
164. J. Zhou, L. Yu, X. Gao, J. Hu, J. Wang, Z. Dai, J. F. Wang, Z. Zhang, S. Lu, X. Huang, Z. Wang, S. Qiu, X. Wang, G. Yang, H. Sun, Z. Tang, Y. Wu, H. Zhu, and J. Fan, Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J. Clin. Oncol. 29, 4781 (2011).
165. J. Xu, C. Wu, X. Che, L. Wang, D. Yu, T. Zhang, L. Huang, H. Li, W. Tan, C. Wang, and D. Lin, Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol. Carcinog. 50, 136 (2011).
166. V. Bihrer, O. Waidmann, M. Friedrich-Rust, N. Forestier, S. Susser, J. Haupenthal, M. Welker, Y. Shi, J. Peveling-Oberhag, A. Polta, M. von Wagner, H. H. Radeke, C. Sarrazin, J. Trojan, S. Zeuzem, B. Kronenberger, and A. Piiper, Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma. PLoS One 6, e26971 (2011).
167. M. J. Alter, Epidemiology of hepatitis B in Europe and worldwide. J. Hepatol. 39 Suppl 1, S64 (2003).
168. B. Custer, S. D. Sullivan, T. K. Hazlet, U. Iloeje, D. L. Veenstra, and K. V. Kowdley, Global epidemiology of hepatitis B virus. J. Clin. Gastroenterol. 38, S158 (2004).
169. D. Lavanchy, Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat. 11, 97 (2004).
170. L. Wu, Z. Diao, X. Deng, J. Gao, Z. Zhou, Y. Liu, and Y. Wang, DNA vaccine against Taenia solium cysticercosis expressed as a modified hepatitis B virus core particle containing three epitopes shared by Taenia crassiceps and Taenia solium. J. Nanosci. Nanotechnol. 5, 1204 (2005).
171. M. Chen, M. Liu, L. Yu, G. Cai, Q. Chen, R. Wu, F. Wang, B. Zhang, T. Jiang, and W. Fu, Construction of a novel peptide nucleic acid piezoelectric gene sensor microarray detection system. J. Nanosci. Nanotechnol. 5, 1266 (2005).
172. J. L. Dienstag, Hepatitis B virus infection. N. Engl. J. Med. 359, 1486 (2008).
173. J. Hou, Y. K. Yin, D. Xu, D. Tan, J. Niu, X. Zhou, Y. Wang, L. Zhu, Y. He, H. Ren, M. Wan, C. Chen, S. Wu, Y. Chen, J. Xu, Q. Wang, L. Wei, G. Chao, B. F. Constance, G. Harb, N. A. Brown, and J. Jia, Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial. Hepatology 47, 447 (2008).
174. H. B. El-Serag, Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142, 1264 (2012).
175. J. J. Ott, G. A. Stevens, J. Groeger, and S. T. Wiersma, Global epidemiology of hepatitis B virus infection: New estimates of agespecific HBsAg seroprevalence and endemicity. Vaccine 30, 2212 (2012).
176. B. J. McMahon, Chronic hepatitis B virus infection. Med. Clin. North Am. 98, 39 (2014).
177. Y. F. Liaw, N. W. Leung, T. T. Chang, R. Guan, D. I. Tai, K. Y. Ng, R. N. Chien, J. Dent, L. Roman, S. Edmundson, and C. L. Lai, Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Gastroenterology 119, 172 (2000).
178. E. Orito, T. Ichida, H. Sakugawa, M. Sata, N. Horiike, K. Hino, K. Okita, T. Okanoue, S. Iino, E. Tanaka, K. Suzuki, H. Watanabe, S. Hige, and M. Mizokami, Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 34, 590 (2001).
179. C. J. Chu and A. S. Lok, Clinical significance of hepatitis B virus genotypes. Hepatology 35, 1274 (2002).
180. C. W. Shepard, E. P. Simard, L. Finelli, A. E. Fiore, and B. P. Bell, Hepatitis B virus infection: Epidemiology and vaccination. Epidemiol. Rev. 28, 112 (2006).
181. C. J. Hoffmann and C. L. Thio, Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect. Dis. 7, 402 (2007).
182. Y. F. Liaw, N. Leung, J. H. Kao, T. Piratvisuth, E. Gane, K. H. Han, R. Guan, G. K. Lau, and S. Locarnini, Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update. Hepatol. Int. 2, 263 (2008).
183. M. Tanaka, F. Katayama, H. Kato, H. Tanaka, J. Wang, Y. L. Qiao, and M. Inoue, Hepatitis B and C virus infection and hepatocellular carcinoma in China: A review of epidemiology and control measures. J. Epidemiol. 21, 401 (2011).
184. Z. Hu, Y. Liu, X. Zhai, J. Dai, G. Jin, L. Wang, L. Zhu, Y. Yang, J. Liu, M. Chu, J. Wen, K. Xie, G. Du, Q. Wang, Y. Zhou, M. Cao, L. Liu, Y. He, Y. Wang, G. Zhou, W. Jia, J. Lu, S. Li, J. Liu, H. Yang, Y. Shi, W. Zhou, and H. Shen, New loci associated with chronic hepatitis B virus infection in Han Chinese. Nat. Genet. 45, 1499 (2013).
185. W. M. Lee, Hepatitis B virus infection. N. Engl. J. Med. 337, 1733 (1997).
186. R. Williams, Global challenges in liver disease. Hepatology 44, 521 (2006).
187. Y. F. Liaw and C. M. Chu, Hepatitis B virus infection. Lancet 373, 582 (2009).
188. F. Ji, B. Yang, X. Peng, H. Ding, H. You, and P. Tien, Circulating microRNAs in hepatitis B virus-infected patients. J. Viral Hepat. 18, e242 (2011).
189. O. Waidmann, V. Bihrer, T. Pleli, H. Farnik, A. Berger, S. Zeuzem, B. Kronenberger, and A. Piiper, Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection. J. Viral Hepat. 19, e58 (2012).
190. R. E. Lanford, E. S. Hildebrandt-Eriksen, A. Petri, R. Persson, M. Lindow, M. E. Munk, S. Kauppinen, and H. Orum, Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198 (2010).
191. R. T. Marquez, S. Bandyopadhyay, E. B. Wendlandt, K. Keck, B. A. Hoffer, M. S. Icardi, R. N. Christensen, W. N. Schmidt, and A. P. McCaffrey, Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab. Invest. 90, 1727 (2010).
192. H. L. Janssen, H. W. Reesink, E. J. Lawitz, S. Zeuzem, M. Rodriguez-Torres, K. Patel, A. J. van der Meer, A. K. Patick, A. Chen, Y. Zhou, R. Persson, B. D. King, S. Kauppinen, A. A. Levin, and M. R. Hodges, Treatment of HCV infection by targeting microRNA. N. Engl. J. Med. 368, 1685 (2013).
193. C. W. Shepard, L. Finelli, and M. J. Alter, Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5, 558 (2005).
194. H. K. Mohd, J. Groeger, A. D. Flaxman, and S. T. Wiersma, Global epidemiology of hepatitis C virus infection: New estimates of agespecific antibody to HCV seroprevalence. Hepatology 57, 1333 (2013).
195. F. V. Chisari, Unscrambling hepatitis C virus-host interactions. Nature 436, 930 (2005).
196. J. J. Feld and J. H. Hoofnagle, Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 436, 967 (2005).
197. C. L. Jopling, M. Yi, A. M. Lancaster, S. M. Lemon, and P. Sarnow, Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309, 1577 (2005).
198. C. L. Jopling, S. Schutz, and P. Sarnow, Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 4, 77 (2008).
199. J. Chang, J. T. Guo, D. Jiang, H. Guo, J. M. Taylor, and T. M. Block, Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells. J. Virol. 82, 8215 (2008).
200. M. Sarasin-Filipowicz, J. Krol, I. Markiewicz, M. H. Heim, and W. Filipowicz, Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat. Med. 15, 31 (2009).
201. R. K. Jangra, M. Yi, and S. M. Lemon, Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122. J. Virol. 84, 6615 (2010).
202. E. S. Machlin, P. Sarnow, and S. M. Sagan, Masking the 5′ terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex. Proc. Natl. Acad. Sci. USA 108, 3193 (2011).
203. T. Shimakami, D. Yamane, R. K. Jangra, B. J. Kempf, C. Spaniel, D. J. Barton, and S. M. Lemon, Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc. Natl. Acad. Sci. USA 109, 941 (2012).
204. V. Bihrer, M. Friedrich-Rust, B. Kronenberger, N. Forestier, J. Haupenthal, Y. Shi, J. Peveling-Oberhag, H. H. Radeke, C. Sarrazin, E. Herrmann, S. Zeuzem, O. Waidmann, and A. Piiper, Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am. J. Gastroenterol. 106, 1663 (2011).
205. S. Cermelli, A. Ruggieri, J. A. Marrero, G. N. Ioannou, and L. Beretta, Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 6, e23937 (2011).
206. J. I. Herrero, B. Sangro, J. Quiroga, F. Pardo, M. Herraiz, J. A. Cienfuegos, and J. Prieto, Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl. 7, 631 (2001).
207. M. Roncalli, P. Bianchi, B. Bruni, L. Laghi, A. Destro, S. D. Gioia, L. Gennari, M. Tommasini, A. Malesci, and G. Coggi, Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma. Hepatology 36, 427 (2002).
208. V. Boige, L. Castera, N. de Roux, N. Ganne-Carrie, B. Ducot, G. Pelletier, M. Beaugrand, and C. Buffet, Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis. Gut 52, 1178 (2003).
209. M. Rocha, P. Avenaud, A. Menard, B. Le Bail, C. Balabaud, P. Bioulac-Sage, Queiroz DM de Magalhaes, and F. Megraud, Association of helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut 54, 396 (2005).
210. K. Matsuzaki, M. Murata, K. Yoshida, G. Sekimoto, Y. Uemura, N. Sakaida, M. Kaibori, Y. Kamiyama, M. Nishizawa, J. Fujisawa, K. Okazaki, and T. Seki, Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor β signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology 46, 48 (2007).
211. Y. F. Yang, W. Zhao, Y. D. Zhong, H. M. Xia, L. Shen, and N. Zhang, Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: A meta-analysis. J. Viral Hepat. 16, 265 (2009).
212. J. Shilpa, G. Naijil, M. S. Nandhu, and C. S. Paulose, Evaluation of GABA-chitosan nanoparticle induced cell signaling activation during liver regeneration after partial hepatectomy. J. Nanosci. Nanotechnol. 12, 6145 (2012).
213. S. L. Friedman and M. B. Bansal, Reversal of hepatic fibrosis-fact or fantasy? Hepatology 43, S82 (2006).
214. Y. Popov and D. Schuppan, Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapies. Hepatology 50, 1294 (2009).
215. V. W. Wong, J. Vergniol, G. L. Wong, J. Foucher, H. L. Chan, B. Le Bail, P. C. Choi, M. Kowo, A. W. Chan, W. Merrouche, J. J. Sung, and V. de Ledinghen, Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51, 454 (2010).
216. N. Bhala, P. Angulo, D. van der Poorten, E. Lee, J. M. Hui, G. Saracco, L. A. Adams, P. Charatcharoenwitthaya, J. H. Topping, E. Bugianesi, C. P. Day, and J. George, The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study. Hepatology 54, 1208 (2011).
217. D. Roulot, J. L. Costes, J. F. Buyck, U. Warzocha, N. Gambier, S. Czernichow, H. Le Clesiau, and M. Beaugrand, Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut 60, 977 (2011).
218. G. Germani, P. Hytiroglou, A. Fotiadu, A. K. Burroughs, and A. P. Dhillon, Assessment of fibrosis and cirrhosis in liver biopsies: An update. Semin. Liver Dis. 31, 82 (2011).
219. E. R. Schiff, S. S. Lee, Y. C. Chao, S. K. Yoon, F. Bessone, S. S. Wu, W. Kryczka, Y. Lurie, A. Gadano, G. Kitis, S. Beebe, D. Xu, H. Tang, and U. Iloeje, Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B. Clin. Gastroenterol. Hepatol. 9, 274 (2011).
220. C. Corpechot, F. Carrat, A. Poujol-Robert, F. Gaouar, D. Wendum, O. Chazouilleres, and R. Poupon, Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology 56, 198 (2012).
221. E. A. Kruglov, P. R. Correa, G. Arora, J. Yu, M. H. Nathanson, and J. A. Dranoff, Molecular basis for calcium signaling in hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G975 (2007).
222. C. Roderburg, T. Mollnow, B. Bongaerts, N. Elfimova, C. D. Vargas, K. Berger, H. Zimmermann, A. Koch, M. Vucur, M. Luedde, C. Hellerbrand, M. Odenthal, C. Trautwein, F. Tacke, and T. Luedde, Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis. PLoS One 7, e32999 (2012).
223. B. Wang, W. Li, K. Guo, Y. Xiao, Y. Wang, and J. Fan, MiR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients. Biochem. Biophys. Res. Commun. 421, 4 (2012).
224. K. Wang, S. Zhang, B. Marzolf, P. Troisch, A. Brightman, Z. Hu, L. E. Hood, and D. J. Galas, Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl. Acad. Sci. USA 106, 4402 (2009).
225. G. Ostapowicz, R. J. Fontana, F. V. Schiodt, A. Larson, T. J. Davern, S. H. Han, T. M. McCashland, A. O. Shakil, J. E. Hay, L. Hynan, J. S. Crippin, A. T. Blei, G. Samuel, J. Reisch, and W. M. Lee. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann. Intern. Med. 137, 947 (2002).
226. W. M. Lee, Acetaminophen and the U.S. acute liver failure study group: Lowering the risks of hepatic failure. Hepatology 40, 6 (2004).
227. A. M. Larson, J. Polson, R. J. Fontana, T. J. Davern, E. Lalani, L. S. Hynan, J. S. Reisch, F. V. Schiodt, G. Ostapowicz, A. O. Shakil, and W. M. Lee, Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. Hepatology 42, 1364 (2005).
228. W. J. Holubek, S. Kalman, and R. S. Hoffman, Acetaminopheninduced acute liver failure: Results of a United States multicenter, prospective study. Hepatology 43, 882 (2006).
229. K. M. Maneshl, J. H. Kim, P. Santhosh, A. I. Gopalan, K. P. Lee, and H. D. Kang, Fabrication of a gold nanoparticles decorated carbon nanotubes based novel modified electrode for the electrochemical detection of glucose. J. Nanosci. Nanotechnol. 7, 3365 (2007).
230. P. Liu, B. Wang, W. Qiao, and J. Li, Novel thermosensitive nanomicelles from triblock copolymer for drug delivery. J. Biomed. Nanotechnol. 5, 310 (2009).
231. N. He, L. Xu, T. Wang, Du J, Z. Li, Y. Deng, S. Li, and S. Ge, Determination of paracetamol with porous electrochemical sensor. J. Biomed. Nanotechnol. 5, 607 (2009).
232. A. Liu, H. Wu, X. Qiu, and W. Tang, Electrochemical behavior of gold nanoparticles modified nitrogen incorporated tetrahedral amorphous carbon and its application in glucose sensing. J. Nanosci. Nanotechnol. 11, 11064 (2011).
233. P. J. S. Lewis, J. Dear, V. Platt, K. J. Simpson, D. G. Craig, D. J. Antoine, N. S. French, N. Dhaun, D. J. Webb, E. M. Costello, J. P. Neoptolemos, J. Moggs, C. E. Goldring, and B. K. Park, Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 54, 1767 (2011).
234. Y. L. Jang, S. H. Ku, S. J. Lee, J. H. Park, W. J. Kim, I. C. Kwon, S. H. Kim, and J. H. Jeong, Hyaluronic acid-siRNA conjugate/ reducible polyethylenimine complexes for targeted siRNA delivery. J. Nanosci. Nanotechnol. 14, 7388 (2014).
235. 2 nanoparticles loaded with small interference RNA: Application to silencing gene expression in primary rat neurons. J. Nanosci. Nanotechnol. 14, 2810 (2014).
236. J. Shen, H. C. Kim, H. Su, F. Wang, J. Wolfram, D. Kirui, J. Mai, C. Mu, L. N. Ji, Z. W. Mao, and H. Shen, Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics. Theranostics 4, 487 (2014).
237. S. Dutta, K. Choudhury, S. D. Banik, and N. Nandi, Active site nanospace of aminoacyl tRNA synthetase: Difference between the class I and class II synthetases. J. Nanosci. Nanotechnol. 14, 2280 (2014).
238. B. Singh, Y. J. Choi, I. K. Park, T. Akaike, and C. S. Cho, Chemical modification of chitosan with pH-sensitive molecules and specific ligands for efficient DNA transfection and siRNA silencing. J. Nanosci. Nanotechnol. 14, 564 (2014).
239. J. Novák, P. Kružliak, J. Bienertová- Vašků, O. Slabý, and M. Novák, MicroRNA-206: A promising theranostic marker. Theranostics 4, 119 (2014).
240. Y. K. Kim, C. S. Cho, M. H. Cho, and H. L. Jiang, Poly(ester amine) synthesized from trimethylolpropane triacrylate and spermine as an efficient siRNA carrier. J. Nanosci. Nanotechnol. 13, 5692 (2013).
241. D. Liu, B. Xu, S. Chen, Y. Yang, X. Zhang, J. Liu, K. Lu, L. Zhang, C. Liu, Y. Zhao, H. Jiang, N. Liu, and M. Chen, Long non-coding RNAs and prostate cancer. J. Nanosci. Nanotechnol. 13, 3186 (2013).
242. L. Jin, X. Zeng, M. Liu, Y. Deng, and N. He, Current progress in gene delivery technology based on chemical methods and nanocarriers. Theranostics 4, 240 (2014).
243. S. P. Yoon, H. H. Kim, J. Kim, R. Y. Park, and T. Ohn, Regulation of cellular RNA nano-particle assembly by splicing factor SRp20. J. Nanosci. Nanotechnol. 13, 184 (2013).
244. M. Zhang, W. Lin, B. Lin, Y. Huang, H. Lin, and J. Qu, Facile preparation of calcium phosphate nanoparticles for siRNA delivery: Effect of synthesis conditions on physicochemical and biological properties. J. Nanosci. Nanotechnol. 12, 9029 (2012).
245. R. Paulmurugan, MicroRNAs - a new generation molecular targets for treating cellular diseases. Theranostics 3, 927 (2013).
246. J. S. Maeng, N. Kim, C. T. Kim, S. R. Han, Y. J. Lee, S. W. Lee, M. H. Lee, and Y. J. Cho. Rapid detection of food pathogens using RNA aptamers-immobilized slide. J. Nanosci. Nanotechnol. 12, 5138 (2012).
247. S. Srinivasan, S. T. Selvan, G. Archunan, B. Gulyas, and P. Padmanabhan, MicroRNAs - the next generation therapeutic targets in human diseases.Theranostics 3, 930 (2013).
248. V. Sanz, H. M. Coley, S. R. P. Silva, and J. McFadden, Protamine and chloroquine enhance gene delivery and expression mediated by RNA-wrapped single walled carbon nanotubes. J. Nanosci. Nanotechnol. 12, 1739 (2012).
249. B. Yoo, S. K. Ghosh, M. Kumar, A. Moore, M. V. Yigit, and Z. Medarova, Design of nanodrugs for miRNA targeting in tumor cells. J. Biomed. Nanotechnol. 10, 1114 (2014).
250. E. W. Hsu, S. Liu, A. R. Shrivats, A. C. S. Watt, S. McBride, S. E. Averick, H. Y. Cho, K. Matyjaszewski, and J. O. Hollinger, Cationic nanostructured polymers for siRNA delivery in murine calvarial pre-osteoblasts. J. Biomed. Nanotechnol. 10, 1130 (2014).
251. F. Berger and M. F. Reiser, Micro-RNAs as potential new molecular biomarkers in oncology: Have they reached relevance for the clinical imaging sciences? Theranostics 3, 943 (2013).
252. M. Muthiah, M. A. Islam, C. S. Cho, J. E. Hwang, I. J. Chung, and I. K. Park, Substrate-mediated delivery of microRNA-145 through a polysorbitol-based osmotically active transporter suppresses smooth muscle cell proliferation: Implications for restenosis treatment. J. Biomed. Nanotechnol. 10, 571 (2014).
253. Q. Shi, P. Liu, Y. Sun, H. Zhang, J. Du, F. Li, L. Du, and Y. Duan, siRNA delivery mediated by copolymer nanoparticles, phospholipid stabilized sulphur hexafluoride microbubbles and ultrasound. J. Biomed. Nanotechnol. 10, 436 (2014).
254. A. Tufman, F. Tian, and R. M. Huber, Can microRNAs improve the management of lung cancer patients? A clinician's perspective. Theranostics 3, 953 (2013).
255. G. Tiram, A. Scomparin, P. Ofek, and R. Satchi-Fainaro, Interfering cancer with polymeric siRNA nanomedicines. J. Biomed. Nanotechnol. 10, 50 (2014).
256. D. Meng, L. Bai, Y. Liang, W. Du, Y. Wang, and L. Chen, Identifying intronic miRNA and mRNA regulatory network in renal cell carcinoma by paired expression data. J. Bionanosci. 7, 551 (2013).
257. T. V. Sekar, R. K. Mohanram, K. Foygel, and R. Paulmurugan, Therapeutic evaluation of microRNAs by molecular imaging. Theranostics 3, 964 (2013).
258. M. C. Santimano, A. Martin, M. Kowshik, and A. Sarkar, Zinc oxide nanoparticles cause morphological changes in human A549 cell line through ateration in the epression pttern of sall GTPases at mRNA level. J. Bionanosci. 7, 300 (2013).
259. S. Wang, S. Hou, J. Wu, and J. Wei, Clustering of ncRNA based on structural and semantic similarity. J. Bionanosci. 7, 20 (2013).
260. S. W. Oh, D. W. Hwang, and D. S. Lee, In vivo monitoring of microRNA biogenesis using reporter gene imaging. Theranostics 3, 1004 (2013).
261. C. Xing, L. Wan, J. Wang, and Y. Liang, Prediction of ncRNA based on least squares support vector machine. J. Bionanosci. 7, 121 (2013).
262. Y. Prasad, K. K. Biswas, C. K. Jain, and M. K. Thakur, siRNA efficacy prediction using multi-task multiple kernel learning. Adv. Sci. Eng. Med. 6, 124 (2014).
263. I. B. Neagoe, C. Braicu, C. Matea, C. Bele, G. Florin, K. Gabriel, C. Veronica, and A. Irimie, Efficient siRNA delivery system using carboxilated single-wall carbon nanotubes in cancer treatment. J. Biomed. Nanotechnol. 8, 567 (2012).
264. H. Tian, S. Liu, J. Zhang, S. Zhang, L. Cheng, C. Li, X. Zhang, L. Dail, P. Fan, L. Dai, N. Yan, R. Wang, Y. Wei, and H. Deng, Enhancement of cisplatin sensitivity in lung cancer xenografts by liposome-mediated delivery of the plasmid expressing small hairpin RNA targeting survivin. J. Biomed. Nanotechnol. 8, 633 (2012).
265. Y. Deng, W. Wang, L. Zhang, Z. Lu, S. Li, and L. Xu, Preparation and electrochemical behavior of L-glutamate electrochemical biosensor. J. Biomed. Nanotechnol. 9, 318 (2013).
266. J. Kakati and P. Datta, Effect of Cu doping on structural, optical and photoluminescence properties of CdS nanoparticles. Adv. Sci. Eng. Med. 5, 1267 (2013).
267. Y. Deng, M. Wang, L. Jiang, C. Ma, Z. Xi, X. Li, and N. He, A comparison of extracellular excitatory amino acids release inhibition of acute Lamotrigine and Topiramate treatment in the hippocampus of PTZ-kindled epileptic rats. J. Biomed. Nanotechnol. 9, 1123 (2013).
268. P. Gupta, D. Kumar, M. A. Quraishi, and O. Parkash, Effect of cobalt oxide doping on the corrosion behavior of iron-alumina metal matrix nanocomposites. Adv. Sci. Eng. Med. 5, 1279 (2013).
269. Y. Deng, W. Wang, C. Ma, and Z. Li, Fabrication of an electrochemical biosensor array for simultaneous detection of L-glutamate and acetylcholine. J. Biomed. Nanotechnol. 9, 1378 (2013).
270. P. Balamohan, C. H. Anjali, and A. Ravindran, Nanoemulsion: Synthesis, characterization and its applications. J. Bionanosci. 7, 323 (2013).
271. C. Ma, C. Li, F. Wang, N. Ma, Z. Li, Z. Xi, X. Li, and N. He, Magnetic nanoparticles-based extraction and verification of nucleic acids from different sources. J. Biomed. Nanotechnol. 9, 703 (2013).
272. A. Mewada, M. Thakur, S. Pandey, G. O. R. Shah, and M. Sharon, A novel one pot synthesis of super stable silver nanoparticles using natural plant exudate from Azadirachta indica (Neem gum) and their inimical effect on pathogenic microorganisms. J. Bionanosci. 7, 296 (2013).
273. N. He, F. Wang, C. Ma, C. Li, X. Zeng, Y. Deng, L. Zhang, and Z. Li, Chemiluminescence analysis for HBV-DNA hybridization detection with magnetic nanoparticles based DNA extraction from positive whole blood samples. J. Biomed. Nanotechnol. 9, 267 (2013).
274. S. Elingarami, X. Li, and N. He, Applications of nanotechnology, next generation sequencing and microarrays in biomedical research. J. Nanosci. Nanotechnol. 13, 4539 (2013).
275. I. Uddin, P. Poddar, U. kumar, and N. Phogat, A novel microbial bio-milling technique for the size reduction of micron sized Gd2O3 particles into nanosized particles. J. Green Sci. Technol. 1, 48 (2013).
276. X. Li, F. Zhang, C. Ma, S. Elingarami, and N. He, Preparation of ZnO nanowire using sludge from wastewater treatment. J. Nanosci. Nanotechnol. 13, 5859 (2013).
277. S. Yan, Y. Shi, B. Zhao, M. Zhou, X. Lan, M. Zhang, C. Liu, and H. Guan, Preparation of CdS/functionalized graphene sheets nanocomposites and its photoelectric properties. J. Green Sci. Technol. 1, 61 (2013).
278. L. Jin, X. Zeng, M. Liu, and N. He, Chitosan/polylactic acid/tripolyphosphate nanocapsules for encapsulation of waterinsoluble drugs: in vitro drug release and cytotoxicity. Sci. Adv. Mater. 5, 2053 (2013).
279. B. S. Mithila, N. R. Ravikumara, and B. Madhusudhan, Preparation, characterization and toxicity evaluation of monodisperse oxytetracycline-loaded poly(hydoxyethylmethacrylate) nanoparticles for oral therapy. J. Bionanosci. 7, 403 (2013).
280. D. Han, J. Hong, H. C. Kim, J. H. Sung, and J. B. Lee, Aptamerbased microspheres for highly sensitive protein detection using fluorescently-labeled DNA nanostructures. J. Nanosci. Nanotechnol. 13, 7259 (2013).
281. Z. Li, H. Yang, N. He, W. Liang, C. Ma, M. A. A. Shah, Y. Tang, S. Li, H. Liu, H. Jiang, and Y. Guo, Solid-phase hybridization efficiency improvement on the magnetic nanoparticle surface by using dextran as molecular arms. J. Biomed. Nanotechnol. 9, 1945 (2013).
282. F. Xu, M. Hua, L. Luo, H. Du, and Y. Yang, Electrochemical aptamer sensor for thrombin detection based on Au nanoneedle and enzymatic ascorbic acid oxidization. J. Nanosci. Nanotechnol. 13, 558 (2013).
283. 2@Au magnetic nanocomposites with low fluorescence background. J. Biomed. Nanotechnol. 9, 674 (2013).
284. S. Lian, P. Zhang, P. Gong, D. Hu, B. Shi, C. Zeng, and L. Cai, A universal quantum dots-aptamer probe for efficient cancer detection and targeted imaging. J. Nanosci. Nanotechnol. 12, 7703 (2012).
285. X. Ji, T. Wang, L. Guo, J. Xiao, Z. Li, L. Zhang, Y. Deng, and N. He, Effection of nano-ZnO on the mechanical property and biocompatibility of electrospun poly(L-lactide) acid/nano-ZnO mats. J. Biomed. Nanotechnol. 9, 417 (2013).
286. Y. Tang, Z. Li, N. He, L. Zhang, C. Ma, X. Li, C. Li, Z. Wang, Y. Deng, and L. He, Preparation of functionial magnetic nanoparticles mediated with PEG-4000 and application in Pseudomonas aeruginosa rapid detection. J. Biomed. Nanotechnol. 9, 312 (2013).
287. Y. Nam, J. Park, Y. K. Pak, and J. J. Pak, Aptamer-based immunosensor on the ZnO nanorods networks. J. Nanosci. Nanotechnol. 12, 5547 (2012).
288. B. Liu, Y. Jia, M. Ma, Z. Li, H. Liu, S. Li, Y. Deng, L. Zhang, Z. Lu, W. Wang, and N. He, High throughput SNP detection system based on magnetic nanoparticles separation. J. Biomed. Nanotechnol. 9, 247 (2013).
289. J. Kulveit, P. Demo, K. Polák, A. Sveshnikov, and Z. Kožíšek, Formation of structured nanophases in halide crystals. Adv. Sci. Eng. Med. 5, 561 (2013).
290. Z. Ali, Y. Deng, Y. Tang, S. Zheng, N. Ma, and N. He, Epigenetic deregulations in gastric cancer. J. Nanosci. Nanotechnol. 13, 40 (2013).
291. J. Lunácek, P. Hlubina, M. Lesnák, D. Ciprian, and M. Lunácková, Surface plasmon resonance sensor using spectral interference. Adv. Sci. Eng. Med. 5, 577 (2013).
292. H. Jiang, X. Zeng, N. He, Y. Deng, G. Lu, and K. Li, Current progress in preparation and biomedical applications of goldcoated magnetic nanocomposites.J. Nanosci. Nanotechnol. 13, 1617 (2013).
293. A. Sveshnikov, I. Klicmanová, P. Demo, and Z. Koží šek, Preliminary study of polyvinyl alcohol nanotextile produced by electrospinning. Adv. Sci. Eng. Med. 5, 569 (2013).
294. S. Elingarami, M. Liu, Z. Li, and N. He, Surface-engineered magnetic nanoparticles for molecular detection of infectious agents and cancer.J. Nanosci. Nanotechnol. 13, 3204 (2013).
295. Š. Potocký, A. Kromka, O. Babchenko, B. Rezek, L. Martinová, and P. Pokorný, Diamond structures grown from polymer composite nanofibers. Adv. Sci. Eng. Med. 5, 519 (2013).
296. M. Mohan Varma, V. Sravani, and P. V. Swamy, Design and evaluation of electrospun nanofibers for the enhancement of dissolution rate of meloxicam. J. Bionanosci. 7, 561 (2013).
297. V. Ghosh, A. Mukherjee, and N. Chandrasekaran, Influence of process parameters on droplet size of nanoemulsion formulated by ultrasound cavitation. J. Bionanosci. 7, 581 (2013).
298. S. S. Mukhopadhyay and S. Sharma, Nanoscience and nanotechnology: Cracking prodigal farming.J. Bionanosci. 7, 497 (2013).
299. J. Feng, Y. Liang, J. Yu, J. Chen, and G. Duns, Molecular survey of viruses infecting chlorella vulgaris by sequencing determination. J. Green Sci. Technol. 1, 54 (2013).
300. N. He, X. Mou, Y. Deng, H. Liu, S. Li, L. Xu, and X. Li, Conditions of PCR amplification by magnetic enrichment and nanoscale detection sensitivity. J. Nanosci. Nanotechnol. 12, 3862 (2012).
301. M. Ahmadi and L. Ahmadi, A human rights approach to international environment rights of applications of nanomaterials in bionanotechnology. J. Bionanosci. 7, 503 (2013).
302. Y. Tang, J. Zou, C. Ma, Z. Ali, Z. Li, X. Li, N. Ma, X. Mou, Y. Deng, L. Zhang, K. Li, G. Lu, H. Yang, and N. He, Highly sensitive and rapid detection of pseudomonas aeruginosa based on magnetic enrichment and magnetic separation. Theranostics 3, 85 (2013).
303. M. Sathasivam, R. S. L. Aparna, R. G. S. V. Prasad, and K. Y. Cheok, Photocatalytic effect of titanium dioxide nanoparticles and effect of copper as a dopant in degradation of dibutyl pthalate and butylhydroxyanisole. J. Bionanosci. 7, 569 (2013).
304. S. Li, H. Liu, Y. Jia, Y. Deng, L. Zhang, Z. Lu, and N. He, A novel SNPs detection method based on gold magnetic nanoparticles array and single base extension. Theranostics 2, 967 (2012).
305. R. Raliya, I. Rathore, and J. C. Tarafdar, Development of microbial nanofactory for Zinc, Magnesium, and Titanium nanoparticles production using soil fungi. J. Bionanosci. 7, 591 (2013).
306. C. Li, C. Ma, F. Wang, Z. Xi, Z. Wang, Y. Deng, and N. He, Preparation and biomedical applications of core-shell silica/magnetic nanoparticle composites. J. Nanosci. Nanotechnol. 12, 2964 (2012).
307. S. Elingarami, M. Liu, J. Fan, and N. Y. He, Applications of nanotechnology in gastric cancer: Detection and prevention by nutrition. J. Nanosci. Nanotechnol. 14, 932 (2014).
308. Y. J. Zhao, X. W. Zhao, and Z. Z. Gu, Photonic crystals in bioassays. Adv. Funct. Mater. 20, 2970 (2010).
309. J. Li, W. Y. Xu, and Z. Z. Gu, Multiplex label-free detection of biomolecules with an imprinted suspension array. Angew. Chem. Int. Ed. 48, 7350 (2009).
310. L. M. Zhang, K. Xia, Y. Deng, S. Li, C. X. Zhang, Z. X. Lu, and N. Y. He, Methoxy poly(ethylene glycol) conjugated doxorubicin micelles for effective killing of cancer cells. J. Nanosci. Nanotechnol. 14, 6458 (2014).
311. M. A. Shah, S. U. Khan, Z. Ali, H. W. Yang, K. K. Liu, and L. L. Mao, Applications of nanoparticles for DNA based rabies vaccine. J. Nanosci. Nanotechnol. 14, 881 (2014).
312. J. Li, X. W. Zhao, Y. J. Zhao, and Z. Z. Gu, Quantum-dot-coated encoded silica colloidal crystals beads for multiplex coding. Chem. Commun. 17, 2329 (2009).
313. Y. J. Tang, Z. Ali, J. Zou, K. Yang, X. B. Mou, Z. Y. Li, Y. Deng, Z. X. Lu, C. Ma, M. A. Shah, S. Elingarami, H. W. Yang, and N. Y. He, Detection of Pseudomonas aeruginosa based on magnetic enrichment and nested PCR. J. Nanosci. Nanotechnol. 14, 4886 (2014).
314. L. M. Zhang, Z. X. Wang, Z. X. Lu, K. Xia, Y. Deng, S. Li, C. X. Zhang, Y. F. Huang, and N. Y. He, Synthesis of LiYF4: Yb, Er upconversion nanoparticles and its fluorescence properties. J. Nanosci. Nanotechnol. 14, 4710 (2014).
315. L. B. Nie, X. L. Wang, S. Li, and H. Chen, Amplification of fluorescence detection of DNA based on magnetic separation. Anal. Sci. 25, 1327 (2009).
316. T. Bora and J. Dutta, Applications of nanotechnology in wastewater treatment-a review. J. Nanosci. Nanotechnol. 14, 613 (2014).
317. X. L. Li, N. Y. He, T. T. Li, C. Ma, S. Elingarami, and F. Q. Zhang, Removal of caramel pigment by electrocoagulation and re-usage of sludge for the preparation of nanoparticles. Sci. Adv. Mater. 6, 822 (2014).
318. L. B. Nie, Y. Yang, S. Li, and N. Y. He, Enhanced DNA detection based on the amplification of gold nanoparticles using quartz crystal microbalance. Nanotechnology 18, 551 (2007).
319. N. N. Ma, C. Ma, N. Y. Wang, C. Y. Li, S. Elingarami, X. B. Mou, Y. J. Tang, S. Zheng, and N. Y. He, Application of functional microsphere in human hepatitis B virus surface antigen detection. J. Nanosci. Nanotechnol. 14, 3348 (2014).
320. A. K. Yagati, J. Min, and J. W. Choi, Recombinant protein-based nanoscale biomemory devices. J. Nanosci. Nanotechnol. 14, 433 (2014).
321. 2@Au nanocomposites and multiplex ligation-dependent probe amplification. J. Nanosci. Nanotechnol. 14, 8910 (2014).
322. H. W. Yang, Y. F. Guo, S. Li, G. Q. Lan, Q. Y. Jiang, X. R. Yang, J. Fan, Z. Ali, Y. J. Tang, X. B. Mou, H. N. Liu, M. A. Shah, S. Jin, H. S. Jiang, and Z. Y. Li, Magnetic beads-based chemiluminescent assay for ultrasensitive detection of pseudorabies virus. J. Nanosci. Nanotechnol. 14, 3337 (2014).
323. Y. J. Zhao, H. C. Shum, H. S. Chen, L. L. Adams, Z. Z. Gu, and D. A. Weitz, Microfluidic generation of multifunctional quantum dot barcode particles. J. Am. Chem. Soc. 133, 8790 (2011).
324. H. S. Lin and J. R. Carey, The design and applications of nanoparticle coated microspheres in immunoassays. J. Nanosci. Nanotechnol. 14, 363 (2014).
325. L. B. Nie, Z. Chen, H. J. Zou, and H. Chang, Development of flowing automatic quartz crystal microbalance system for DNA detection. J. Nanosci. Nanotechnol. 13, 2077 (2013).
326. L. M. Zhang, K. Xia, Z. X. Lu, G. P. Li, J. Chen, Y. Deng, S. Li, F. M. Zhou, and N. Y. He, Efficient and facile synthesis of gold nanorods with finely tunable plasmonic peaks from visible to near-IR range. Chem. Mater. 26, 1794 (2014).
327. B. W. Boote, H. Byun, and J. H. Kim, Silver-gold bimetallic nanoparticles and their applications as optical materials. J. Nanosci. Nanotechnol. 14, 1563 (2014).
328. Z. F. Wang, S. Zheng, J. Cai, P. Wang, J. Feng, X. X. Yang, L. M. Zhang, M. Ji, F. G. Wu, N. Y. He, and N. Wan, Fluorescent artificial enzyme-linked immunoassay system based on Pd/C nanocatalyst and fluorescent chemodosimeter, Anal. Chem. 85, 11602 (2013).
329. Y. Zhang, Y. Jia, S. Li, Y. Deng, H. Liu, and N. He, Genotyping of -765G >C in COX-2 gene based on MNPs and dual-color fluorescence hybridization and its association with risk of gastric cancer in Northern Jiangsu of China. Sci. Adv. Mater. 6, 1146 (2014).
330. M. Famulok and J. W. Szostak, Stereospecific recognition of tryptophan agarose by in vitro selected RNA. J. Am. Chem. Soc. 114, 3990 (1992).
331. I. Hirao, Y. Harada, T. Nojima, Y. Osawa, H. Masaki, and S. Yokoyama, In vitro selection of RNA aptamers that bind to Colicin E3 and structurally resemble the decoding site of 16S ribosomal RNA. Biochemistry 43, 3214 (2004).
332. 2@Au magnetic nanoparticles and association of the genotypes with gastric cancer risk in Northern Jiangsu (China). Sci. Adv. Mater. 6, 899 (2014).
333. I. Majerfeld and M. Yarus, An RNA pocket for an aliphatic hydrophobe. Nat. Struct. Mol. Biol. 1, 287 (1994).
334. K. Kagan and T. Eiichi, Aptamer-functionalized Au nanoparticles for the electrochemical detection of thrombin. J. Biomed. Nanotechnol. 4, 159 (2008).
335. Z. C. Liu, X. Zhang, N. Y. He, Z. H. Lu, and Z. C. Chen, Probing DNA hybridization efficiency and single base mismatch by X-ray photoelectron spectroscopy. Colloid. Surface. B 71, 238 (2009).
336. F. Wahid, T. Khan, A. Shehzad, M. Ul-Islam, and Y. Y. Kim, Interaction of nanomaterials with cells and their medical applications. J. Nanosci. Nanotechnol. 14, 744 (2014).
337. L. M. Liao and C. N. He, Nanoparticle-dependent labeling of mesenchymal stem cell. J. Nanosci. Nanotechnol. 14, 958 (2014).
338. M. Morenoa, E. Rincona, D. Pineirob, G. Fernandeza, A. Domingoa, A. Jimenez-Ruiza, M. Salinasb, and V. M. Gonzalez, Selection of aptamers against KMP-11 using colloidal gold during the SELEX process. Biochem. Biophys. Res. Commun. 308, 214 (2003).
339. E. Kim, W. B. Jeon, S. Kim, and S. K. Lee, Decrease of reactive oxygen species-related biomarkers in the tissue-mimic 3D spheroid culture of human lung cells exposed to zinc oxide nanoparticles. J. Nanosci. Nanotechnol. 14, 3356 (2014).
340. H. Liu, S. Li, Z. Wang, P. Hou, Q. He, and N. He, PCR amplification on magnetic nanoparticles: Application for high-throughput single nucleotide polymorphism genotyping. Biotechnol. J. 2, 508 (2007).
341. B. K. Bindhani, U. K. Parida, S. K. Biswal, A. K. Panigrahi, and P. L. Nayak, Gold nanoparticles and their biomedical applications. Rev. Nanosci. Nanotechnol. 2, 247 (2013).
342. S. Li, H. Liu, Z. Wang, M. Ji, N. He, and Y. Dai, A novel in situ magnetic particle PCR based high-throughput genotyping method using universal tags. Prog. Biochem. Biophys. 34, 1107 (2007).
343. B. K. Nanjwade, V. T. Kadam, and T. Srichana, Nanoemulsions formation and their potential applications. Rev. Nanosci. Nanotechnol. 2, 261 (2013).
344. H. Liu, S. Li, L. Liu, L. Tian, Y. Deng, Z. Li, and N. He, Single nucleotide polymorphism genotyping based on magnetic bead array and dual-color hybridization. Chinese J. Anal. Chem. 38, 1708 (2010).
345. J. Singh, W. Mohammed-Saied, R. Kaur, and I. Badea, Nanoparticles in gene therapy: From design to clinical applications. Rev. Nanosci. Nanotechnol. 2, 275 (2013).
346. H. Liu, S. Li, L. Liu, L. Tian, Y. Deng, Z. Li, and N. He, Magnetic particle-based single nucleotide polymorphism detection method using linker-polymerase chain reaction. Acta Chim. Sinica 67, 1797 (2009).
347. S. Vaidya, A. Kar, A. Patra, and A. K. Ganguli, Core-Shell (CS) nanostructures and their application based on magnetic and optical properties. Rev. Nanosci. Nanotechnol. 2, 106 (2013).
348. H. Liu, S. Li, Z. Wang, N. He, and Q. He, High-throughput SNP genotypying method with PCR on magnetic nanoparticles. Chem. J. Chinese U. 28, 1035, (2007).
349. N. Rozanova and J. Z. Zhang, Metal and magnetic nanostructures for cancer diagnosis and therapy. Rev. Nanosci. Nanotechnol. 2, 29 (2013).
350. S. Li, H. Liu, Z. Wang, P. Hou, Y. Guo, Q. He, and N. He, Magnetic particles-based high-throughput genotyping method with dual-color fluorescence hybridization. Anal. Biochem. 359, 277 (2006).
351. L. Carlini, H. Chibli, X. Zhang, and J. Nadeau, Comparative anticancer properties of quantum dots and gold particles conjugated to chemotherapeutic agents. Rev. Nanosci. Nanotechnol. 2, 42 (2013).
352. H. Liu, S. Li, Z. Wang, M. Ji, L. Nie, and N. He, High-throughput SNP genotyping based on solid-phase PCR on magnetic nanoparticles with dual-color hybridization. J. Biotechnol. 131, 217 (2007).
353. A. Kleinauskas, J. K. Kim, G. H. Choi, H. T. Kim, K. Røe, and P. Juzenas, Superparamagnetic magnetite nanoparticles for cancer theranostics. Rev. Nanosci. Nanotechnol. 1, 271 (2012).
354. H. Liu, S. Li, Z. Wang, Z. Li, Y. Deng, H. Wang, Z. Shi, and N. He, Automated detection system of single nucleotide polymorphisms using two kinds of functional magnetic nanoparticles. Appl. Surf. Sci. 255, 600 (2008).
355. A. S. Wadajkar, J. U. Menon, and K. T. Nguyen, Polymer-coated magnetic nanoparticles for cancer diagnosis and therapy. Rev. Nanosci. Nanotechnol. 1, 284 (2012).
356. A. Lad and Y. K. Agrawal, Nanodevices for monitoring toxicological behavior of therapeutic agent. Rev. Nanosci. Nanotechnol. 1, 217 (2012).
357. L. Tian, S. Li, H. Liu, Z. Wang, and N. He, An automated magstation for high-throughput SNP genotyping and the dual-color hybridization. J. Biomed. Nanotechnol. 5, 511 (2009).
358. Y. Liu, S. Shah, and J. Tan, Computational modeling of nanoparticle targeted drug delivery. Rev. Nanosci. Nanotechnol. 1, 66 (2012).
359. H. Liu, S. Li, L. Liu, L. Tian, and N. He, Multiplex single nucleotide polymorphisms genotyping using solid-phase single base extension on magnetic nanoparticles. Anal. Biochem. 386, 126 (2009).
360. G. A. Evtugyn, V. B. Stepanova, A. V. Porfireva, A. I. Zamaleeva, and R. R. Fakhrullin, Electrochemical DNA sensors based on nanostructured organic dyes/DNA/polyelectrolyte complexes. J. Nanosci. Nanotechnol. 14, 6738 (2014).
361. H. Liu, S. Li, L. Liu, L. Tian, and N. He, An integrated and sensitive detection platform for biosensing application based on Fe@Au magnetic nanoparticles as bead array carries. Biosens. Bioelectron. 26, 1442 (2010).
362. G. Lim, H. J. Hwang, and J. H. Kim, Effect of surface hydrophobicity on activity of immobilized Taq DNA polymerase, its reusability and storage. J. Nanosci. Nanotechnol. 14, 6452 (2014).
363. M. Rajasekaran and J. Annaraj, A lucid build-up of nanostructured curcumin, quercetin and their interaction with DNA. J. Nanosci. Nanotechnol. 14, 4874 (2014).
364. S. Li, H. Liu, L. Liu, L. Tian, and N. He, A novel automated assay with dual-color hybridization for single-nucleotide 4 polymorphisms genotyping on gold magnetic nanoparticle array. Anal. Biochem. 405, 141 (2010).
365. X. Du, H. An, B. Jin, L. Meng, and Q. Liu, Carbon nanotubes altering specificity of repeated PCR and DNA integrity properties. J. Nanosci. Nanotechnol. 14, 5547 (2014).
366. L. Zhang, Y. Xing, N. He, Y. Zhang, Z. Lu, J. Zhang, and Z. Zhang, Preparation of graphene quantum dots for bioimaging application. J. Nanosci. Nanotechnol. 12, 2924 (2012).
367. J. Kim, J. H. Park, S. Lee, and H. J. Shin, Simple and easy DNA mapping method using peptide nucleic acid (PNA) tagging. J. Nanosci. Nanotechnol. 14, 2477 (2014).
368. B. Das, D. Sarkar, M. Mandal, P. Das, and K. Mandal, DNA engineered tri-functional Ni-Au nano-chain: Understanding of its formation and novel magnetic properties. J. Nanosci. Nanotechnol. 14, 2599 (2014).
369. S. Nimesh, N. Gupta, and R. Chandra, Cationic polymer based nanocarriers for delivery of therapeutic nucleic acids. J. Biomed. Nanotechnol. 7, 504 (2011).
370. S. W. Han, C. Nakamura, J. Miyake, S. M. Chang, and T. Adachi, Single-cell manipulation and DNA delivery technology using atomic force microscopy and nanoneedle. J. Nanosci. Nanotechnol. 14, 57 (2014).
371. S. Li, M. Ji, P. Hou, N. He, and H. Chen, Application of micro array-based method for functional SNP genotyping in the risk of gastric carcinoma in Chinese population. Rare Metal Mat. Eng. 35, 467 (2006).
372. D. G. Park, H. Song, M. B. Kishore, G. Vértesy, and D. H. Lee, Detection of gamma-irradiation effect on DNA and protein using magnetic sensor and cyclic voltammetry. J. Nanosci. Nanotechnol. 13, 7250 (2013).
373. M. Naresh, M. Sharma, and A. Mittal, Intracellular magneto-spatial organization of magnetic organelles inside intact bacterial cells. J. Biomed. Nanotechnol. 7, 572 (2011).
374. J. H. Heo, K. I. Kim, M. H. Lee, and J. H. Lee, Stability of a gold nanoparticle-DNA system in seawater. J. Nanosci. Nanotechnol. 13, 7254 (2013).
375. 2 microspheres and its application for magnetic separation of nucleic acids from E. coli BL21. J. Biomed. Nanotechnol. 8, 1000 (2012).
376. S. Li, H. Liu, Y. Jia, X. Mou, Y. Deng, L. Lin, B. Liu, and N. He, An automatic high-throughput single nucleotide polymorphism genotyping approach based on universal tagged arrays and magnetic nanoparticles. J. Biomed. Nanotechnol. 9, 689 (2013).
377. S. Cho, Y. Oh, and S. M. Ahn, Influence of DNA concentration on the interfacial electrode impedance. J. Nanosci. Nanotechnol. 13, 7291 (2013).
378. L. Xiao, J. Zhang, P. Sirois, N. He, and K. Li, A new strategy for next generation sequencing: Merging the Sanger's method and the sequencing by synthesis through replacing extension. J. Biomed. Nanotechnol. 7, 568 (2011).
379. D. Han, J. Hong, H. C. Kim, J. H. Sung, and J. B. Lee, Multiplexing enhancement for the detection of multiple pathogen DNA. J. Nanosci. Nanotechnol. 13, 7295 (2013).
380. J. Fu, Z. Dang, Y. Deng, and G. Lu, Regulation of c-Myc and Bcl-2 induced apoptosis of human bronchial epithelial cells by zinc oxide nanoparticles. J. Biomed. Nanotechnol. 8, 669 (2012).
381. H. N. Noh and J. S. Kim, Detection of K-ras oncogene from the human genomic DNA using ultrasonication and a quantum dotsbased microfluidic chip. J. Nanosci. Nanotechnol. 13, 6033 (2013).
382. S. Li, H. Liu, Y. Deng, L. Lin, and N. He, Development of a magnetic nanoparticles microarray for simultaneous and simple detection of foodborne pathogens. J. Biomed. Nanotechnol. 9, 1254 (2013).
383. M. S. Cha, J. K. Lee, S. H. Cho, J. G. Park, H. Y. Lee, S. H. Lim, and Y. R. Yoon, Quantitative analysis of H5N1 DNA hybridization on nanowell array electrode. J. Nanosci. Nanotechnol. 13, 5245 (2013).
384. W. Wang, Y. Deng, X. He, L. Xu, and Z. Li, Progress in preparation and application of nanostructured neurotransmitters microsensors/microelectrodes. J. Nanosci. Nanotechnol. 12, 7301 (2012).
385. J. H. Yoo and J. S. Kim, Rapid detection of specific genes from human genomic DNA using the microbead-quantum dot complexes in microfluidic chip. J. Nanosci. Nanotechnol. 13, 5250 (2013).
386. S. Mohammadi, S. Khoei, and S. R. Mahdavi, The combination effect of poly(lactic-co-glycolic acid) coated iron oxide nanoparticles as 5-fluorouracil carrier and X-ray on the level of DNA damages in the DU 145 human prostate carcinoma cell line. J. Bionanosci. 6, 23 (2012)
387. H. Jia, X. Cao, C. Fu, J. Wang, Z. Chen, B. Zou, L. Jin, Z. Yan, and G. Zhou, Colorimetric detection of DNA sequences using an organic solvent to induce the aggregation of label-free gold nanoparticles. J. Nanosci. Nanotechnol. 13, 3805 (2013).
388. D. Rawtani and Y. K. Agrawal, Study the interaction of DNA with halloysite nanotube-gold nanoparticle based composite. J. Bionanosci. 6, 95 (2012).
389. C. Wang, S. Wang, Q. Xia, W. He, J. Yin, P. P. Fu, and J. Li, Phototoxicity of zinc oxide nanoparticles in HaCaT keratinocytesgeneration of oxidative DNA damage during UVA and visible light irradiation. J. Nanosci. Nanotechnol. 13, 3880 (2013).
390. Y. S. Joe, S. H. Lee, E. R. Hedin, and Y. D. Kim, Temperature and magnetic field effects on electron transport through DNA molecules in a two-dimensional four-channel system. J. Nanosci. Nanotechnol. 13, 3889 (2013).
391. A. Yahya, R. Zulkifli, M. Arif, T. Andromeda, N. A. Ahmad, M. R. A. Kadir, and A. Baharom, Development of gel electrophoresis unit to reduce DNA separation process time - a proof of concept. J. Bionanosci. 7, 210 (2013).
392. M. K. Patel, J. Singh, M. K. Singh, V. V. Agrawal, S. G. Ansari, and B. D. Malhotra, Tin oxide quantum dot based DNA sensor for pathogen detection. J. Nanosci. Nanotechnol. 13, 1671 (2013).
393. Y. Wang, R. Shi, Z. Wang, X. Zhang, and G. Cui, Design of DNA sequences for stable DNA tile. J. Bionanosci. 7, 265 (2013).
394. K. Kyhm, I. Kim, M. Kang, and H. Y. Woo, Ultrafast dynamics of Förster Resonance Energy Transfer and photo-induced charge transfer in cationic polyfluorene/dye-labeled DNA complex. J. Nanosci. Nanotechnol. 12, 7733 (2012).
395. S. Han and G. Chang, A novel method of characterizing DNA sequences based on complete composition and position vector. J. Bionanosci. 7, 453 (2013).
396. J. Ahn, S. H. Kim, J. Woo, and Y. J. Park, Comparative analysis of electrical detection methods of DNA synthesis. J. Nanosci. Nanotechnol. 12, 5125 (2012).
397. J. Park, Y. E. Pak, H. Chun, and J. Lee, 3-D Simulation of nanopore structure for DNA sequencing. J. Nanosci. Nanotechnol. 12, 5160 (2012).
398. Y. Bai, Q. Han, D. Lin, J. Luo, J. Tu, Q. Ge, and Z. Lu, Structure-function relationships of three kinds of immobilized DNA probes in the discrimination abilities of single nucleotide variation. J. Nanosci. Nanotechnol. 12, 1748 (2012).
399. W. Lu, X. Qin, G. Chang, and X. Sun, 2,4,6-Tris (2-pyridyl)-1,3,5- triazine nanobelts as an effective fluorescent sensing platform for DNA detection. J. Nanosci. Nanotechnol. 12, 2089 (2012).
400. V. M. Singh, S. J. Newati, and R. A. Khan, Preparation of supramolecular λ-deoxyribose nucleic acid and, multi-walled carbon nanotube bioconjugate (λ-DNA-MW-CNT) towards prototype biosensor development. J. Bionanosci. 7, 420 (2013).
401. H. Chiang, Q. Xia, X. Zou, C. Wang, S. Wang, B. J. Miller, P. C. Howard, J. J. Yin, F. A. Beland, H. Yu, and P. P. Fu, Nano-ZnO induces cytotoxicity and DNA damage in human cell lines and rat primary neuronal cells. J. Nanosci. Nanotechnol. 12, 2126 (2012).
402. M. Veerapandian, B. Kim, R. Amin, J. Lee, K. Yun, and S. H. Park, NMR studies of artificial double-crossover DNA tiles. J. Nanosci. Nanotechnol. 12, 2300 (2012).
403. A. J. Khan, R. A. Khan, V. M. Singh, S. J. Newati, and M. Yusuf, In silico designed, self-assembled, functionalized single-walled carbon nanotubes and, deoxyribose nucleic acids (f-SW-CNT-DNA) bioconjugate as probable biomolecular transporters. J. Bionanosci. 7, 530 (2013).
404. K. Ma, Q. Cui, Y. Shao, F. Wu, S. Xu, and G. Liu, Emission modulation of DNA-templated fluorescent silver nanoclusters by divalent magnesium lon. J. Nanosci. Nanotechnol. 12, 861 (2012).
405. S. M. Hossein, P. K. D. Mohapatra, and D. De, DNA compression and security based on reverse technique. J. Bionanosci. 7, 707 (2013).
406. S. Pu, A. Zinchenko, and S. Murata, Facile control of DNA-templated inorganic nanoshell size. J. Nanosci. Nanotechnol. 12, 635 (2012).